Targeting RET-rearranged non-small-cell lung cancer: future prospects

Non-small-cell lung cancer (NSCLC) patients with mutated or rearranged oncogene drivers can be treated with upfront selective inhibitors achieving higher response rates and longer survival than chemotherapy. The RET gene can undergo chromosomal rearrangements in 1%–2% of all NSCLC patients, involvin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lung Cancer (Auckl)
Main Authors: Bronte, Giuseppe, Ulivi, Paola, Verlicchi, Alberto, Cravero, Paola, Delmonte, Angelo, Crinò, Lucio
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6433115/
https://ncbi.nlm.nih.gov/pubmed/30962732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S192830
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki